Janus Henderson Group plc 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:58 pm Sale |
2024-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
6,034,239 8.700% |
-1,043,239 (-14.74%) |
Filing |
| 2024-11-14 3:59 pm Purchase |
2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
7,077,478 10.200% |
127,060 (+1.83%) |
Filing |
| 2024-06-10 4:17 pm Purchase |
2024-05-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
6,950,418 10.100% |
2,644,017 (+61.40%) |
Filing |
| 2024-02-13 11:31 am Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
4,306,401 7.700% |
966,227 (+28.93%) |
Filing |
| 2023-02-10 11:27 am Purchase |
2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
3,340,174 7.100% |
176,552 (+5.58%) |
Filing |
| 2022-02-10 2:07 pm Sale |
2021-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
3,163,622 9.100% |
-329,797 (-9.44%) |
Filing |
| 2021-02-11 3:50 pm Sale |
2020-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
3,493,419 10.100% |
-13,809 (-0.39%) |
Filing |
| 2020-09-10 2:14 pm Purchase |
2020-08-31 | 13G | Akero Therapeutics, Inc. AKRO |
JANUS HENDERSON GROUP PLC JHG |
3,507,228 10.100% |
1,097,695 (+45.56%) |
Filing |